Voyager Therapeutics, Inc. Financial Ratios — VYGR Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-280.22	-24.63	-19.18	-37.8	-48.84	-16.4	11.92	-31.27	-26.28	51.83	-17.47	-37.1
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	16.32	- -	- -	71.28	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	-113.38	-286.13	-693.32	-1,167.84	-46.86	18.23	-182.96	-109.14	50.58	-98.19	-316.5
Operating Margin (%)	- -	- -	-116.85	-290.43	-709.06	-1,195.63	-49.51	16	-196.76	-124.27	48.8	-104.11	-326.56
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	118.47	- -	- -	82.66	- -	- -
Pretax Margin (%)	- -	- -	-171.18	-282.29	-697.56	-1,161.15	-41.76	21.47	-190.29	-113.41	53.49	-80.42	-296.17
Profit Margin (%)	- -	- -	-171.18	-282.65	-697.56	-1,158.79	-41.76	21.47	-190.29	-113.45	52.93	-81.25	-296.53
Net Income to Common Margin (%)	- -	- -	-178.36	-282.65	-697.56	-1,158.79	-41.76	21.47	-190.29	-113.45	52.93	-81.25	-296.53
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.05	- -	- -
Dvd Payout Ratio (%)	- -	- -	4.03	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	3	- -	- -	- -	- -	- -	34	48	44	23	20	44	36
ST Debt	3	- -	- -	- -	- -	- -	3	4	6	3	3	7	8
LT Debt	- -	- -	- -	- -	- -	- -	31	43	39	20	17	36	29
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	-0.7	1.53	-0.65	-0.52	0.16	-0.56	-0.29
Net Debt/EBITDA	- -	0.5	1.59	0.9	0.45	0.53	1.76	-3.35	1.72	2.22	-0.54	0.91	0.51
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	-0.66	1.74	-0.6	-0.45	0.17	-0.53	-0.28
Net Debt/EBIT	- -	0.49	1.55	0.89	0.44	0.51	1.66	-3.81	1.6	1.95	-0.56	0.86	0.5
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-2,572.48	-181.18	-21.7	-47.47	-87.1	-151.96	-88.12	-105.46	-179.03	-246.92	-74.34	-82.97	-176.73
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	31.13	28.13	40.62	34.38	7.23	12.18	14.62
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-11.12	-19.02	-12.75	-5.48	-7.1	-12.92	-7
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	8.73	16.59	19.92	12.74	4.87	9.29	11.36
Total Debt/Equity (%)	-76.36	- -	- -	- -	- -	- -	34.34	30.85	46.48	39.18	8.59	14.59	18.61
Total Debt/Capital (%)	-323.07	- -	- -	- -	- -	- -	-12.27	-20.86	-14.59	-6.24	-8.43	-15.48	-8.92
Total Debt/Total Assets (%)	1,964.43	- -	- -	- -	- -	- -	9.63	18.2	22.79	14.51	5.78	11.12	14.47
Net Debt to Equity	-72.84	-612.27	-18.52	-26.96	-23.52	-100.89	-86.46	-67.68	-123.54	-167.67	-29.11	-23.81	-33.3
Net Debt/Capital (%)	-268.2	119.52	38.6	28.94	16.4	14.83	23.61	31.39	27.94	21.09	22.22	20.17	13.76
EBITDA	- -	-14	-20	-41	-70	-89	-49	31	-68	-45	126	-79	-128
EBITDA-CapEx	- -	-17	-21	-46	-74	-93	-57	19	-70	-47	123	-82	-130
Operating Income (Loss)	- -	-14	-20	-41	-72	-91	-52	27	-74	-51	122	-83	-132

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.03	2.84	8.12	12.64	10.63	4.92	3.7	6.77	2.6	1.64	3.58	5.36	7.4
Current Ratio	0.03	3.38	8.19	12.95	10.81	5.13	4.01	7.39	2.68	1.72	4.96	5.56	7.64
Quick Ratio	0.03	2.84	8.14	12.8	10.64	4.93	3.95	7.07	2.61	1.65	4.89	5.45	7.51
CFO/Avg Current Liab	- -	-3.69	3.13	-2.25	-4.13	-0.67	0.9	-1.88	-1.38	-0.2	1.14	-0.27	-3.47
Common Equity/Total Assets	-2,572.48	-181.18	-21.7	-47.47	-87.1	-151.96	-88.12	-105.46	-179.03	-246.92	-74.34	-82.97	-176.73
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	31.13	28.13	40.62	34.38	7.23	12.18	14.62
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-11.12	-19.02	-12.75	-5.48	-7.1	-12.92	-7
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	8.73	16.59	19.92	12.74	4.87	9.29	11.36
Total Debt/Equity (%)	-76.36	- -	- -	- -	- -	- -	34.34	30.85	46.48	39.18	8.59	14.59	18.61
Total Debt/Capital (%)	-323.07	- -	- -	- -	- -	- -	-12.27	-20.86	-14.59	-6.24	-8.43	-15.48	-8.92
Total Debt/Total Assets (%)	1,964.43	- -	- -	- -	- -	- -	9.63	18.2	22.79	14.51	5.78	11.12	14.47
CFO/Total Liabilities	- -	-115.17	68.4	-79.19	-121.66	-12.17	19.07	-90.17	-54.18	-12.47	67.78	-16.41	-235.71
CFO/CapEx	- -	-3.99	40.1	-8.45	-15.4	-3.69	6.31	-8	-33.27	-5.02	23.93	-4.35	-51.03
Altman's Z-Score	-67	-6.05	5.8	3.34	3.86	-1.51	0.53	1.79	-2.42	-2.46	3.58	1.14	-3.2

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	11.29	12.91	8.56	111.77	6.24	1.96	24.73
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	32.34	28.27	42.65	3.27	58.51	186.27	14.76
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	546	322	445	301	501	265	102	234	363	327	- -
- Cash & Cash Equivalents	- -	7	31	37	32	47	86	104	117	99	69	71	65
+ Preferred Equity and Hybrid Capital	- -	22	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	- -	- -	- -	- -	- -	34	48	44	23	20	44	36
Enterprise Value	3	15	352	148	276	146	253	132	14	138	153	104	-160
Total Capital	-1	1	-50	-90	-161	-269	-278	-228	-303	-370	-241	-282	-409
Total Debt/Capital (%)	-323.07	- -	- -	- -	- -	- -	-12.27	-20.86	-14.59	-6.24	-8.43	-15.48	-8.92
Total Debt / EV	1.05	- -	- -	- -	- -	- -	0.13	0.36	3.22	0.17	0.13	0.42	-0.23
EV/Sales	- -	- -	20.29	10.4	27.22	19.11	2.43	0.77	0.37	3.38	0.61	1.3	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	4.23	- -	- -	1.21	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	4.82	- -	- -	1.25	- -	- -
EV/Cash Flow to Firm	- -	- -	8.51	- -	- -	- -	5.21	- -	- -	- -	1.96	- -	- -
EV/Free Cash Flow to Firm	- -	- -	8.31	- -	- -	- -	4.49	- -	- -	- -	1.88	- -	- -
Diluted Market Cap	- -	- -	546	322	445	301	501	267	102	234	376	327	- -
Diluted Enterprise Value	3	15	515	286	413	255	449	210	29	158	328	299	-29
EV per Share	- -	1.02	14.1	5.85	10.29	4.54	7.06	3.55	0.36	3.6	3.55	1.8	- -
TTM Sales	- -	- -	17	14	10	8	104	171	37	41	250	80	40
TTM EBITDA	- -	-14	-20	-41	-70	-89	-49	31	-68	-45	126	-79	-128
TTM Operating Income	- -	-14	-20	-41	-72	-91	-52	27	-74	-51	122	-83	-132
TTM Cash Flow to Firm	- -	-12	41	-42	-61	-16	49	-97	-54	-13	78	-15	-132
TTM Free Cash Flow to Firm	- -	-9	42	-37	-57	-12	56	-85	-52	-10	81	-12	-130

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	12.9	-8.61	-7.76	-26.02	8.88	-3.16	-1.97	-23.36	4.63	-27.74	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	4.82	- -	- -	1.25	- -	- -
Enterprise Value	3	15	352	148	276	146	253	132	14	138	153	104	-160
Low Price	- -	- -	14.75	8.12	8.1	8.3	7.76	6.26	2.46	2.6	5.87	5.19	2.65
EV/Sales	- -	- -	20.29	10.4	27.22	19.11	2.43	0.77	0.37	3.38	0.61	1.3	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	4.23	- -	- -	1.21	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	7.23	- -	- -	2.74	- -	- -
Price/Earnings Average	- -	- -	-18.58	-7.87	-4.8	-6.66	-14.74	11.23	-2.37	-4.82	2.82	-6.76	- -
Price/Earnings High	- -	- -	-24.63	-13.8	-9.85	-11.59	-23.71	14.96	-4.84	-8.76	4.66	-10.4	- -
Price/Earnings Low	- -	- -	-11.89	-5.11	-3.07	-3.01	-6.39	6.33	-1.3	-2.15	1.91	-4.6	- -
Price/Book Value	- -	- -	-10.96	-3.58	-2.77	-1.12	-1.6	-0.96	-0.29	-0.59	-1.39	-1	- -
Price/Book Value Average	- -	- -	-11.53	-3.52	-2.11	-2.18	-2.06	-1.5	-0.49	-0.57	-1.43	-1.35	- -
Price/Book Value High	- -	- -	-15.29	-6.16	-4.34	-3.8	-3.31	-1.99	-0.99	-1.03	-2.36	-2.07	- -
Price/Book Value Low	- -	- -	-7.38	-2.28	-1.35	-0.99	-0.89	-0.84	-0.27	-0.25	-0.97	-0.92	- -
Price/Tangible Book Value	- -	- -	3.23	2.37	3.32	6.49	5.03	1.72	1.07	3.96	1.54	1.09	- -
Price/Tangible Book Value Average	- -	- -	3.4	2.33	2.53	12.65	6.46	2.67	1.77	3.79	1.58	1.47	- -
Price/Tangible Book Value High	- -	- -	4.5	4.08	5.2	22.03	10.39	3.56	3.63	6.89	2.61	2.25	- -
Price/Tangible Book Value Low	- -	- -	2.17	1.51	1.62	5.73	2.8	1.51	0.97	1.69	1.07	1	- -
Price/Sales	- -	- -	31.5	22.67	43.9	39.56	4.8	1.55	2.73	5.72	1.45	4.09	- -
Price/Sales Average	- -	- -	33.13	22.24	33.48	77.14	6.15	2.41	4.51	5.47	1.49	5.5	- -
Price/Sales High	- -	- -	43.92	39	68.73	134.3	9.9	3.21	9.21	9.94	2.47	8.45	- -
Price/Sales Low	- -	- -	21.21	14.45	21.42	34.93	2.67	1.36	2.48	2.44	1.01	3.74	- -
Price/Cash Flow	- -	- -	13.22	-7.59	-7.25	-18.97	10.29	-2.75	-1.91	-18.7	4.66	-21.36	- -
Price/Cash Flow Average	- -	- -	13.91	-7.45	-5.53	-36.99	13.2	-4.27	-3.15	-17.87	4.79	-28.71	- -
Price/Cash Flow High	- -	- -	18.44	-13.06	-11.35	-64.41	21.24	-5.68	-6.44	-32.5	7.92	-44.15	- -
Price/Cash Flow Low	- -	- -	8.9	-4.84	-3.54	-16.75	5.72	-2.4	-1.73	-7.97	3.24	-19.55	- -
Price/Free Cash Flow Average	- -	- -	13.57	-8.45	-5.92	-50.74	11.39	-4.9	-3.25	-22.32	4.76	-37.29	- -
Price/Free Cash Flow High	- -	- -	17.99	-14.81	-12.14	-88.35	18.33	-6.53	-6.64	-40.59	7.87	-57.33	- -
Price/Free Cash Flow Low	- -	- -	8.69	-5.49	-3.78	-22.98	4.94	-2.76	-1.78	-9.95	3.22	-25.39	- -
EV/Sales Average	- -	- -	31.32	19.67	30.37	70.99	5.66	2.08	2.55	3.61	1.3	5.15	- -
EV/Sales High	- -	- -	42.12	36.43	65.62	128.15	9.4	2.88	7.25	8.09	2.27	8.1	- -
EV/Sales Low	- -	- -	19.41	11.87	18.31	28.78	2.17	1.03	0.52	0.58	0.82	3.4	- -
EV/EBITDA Average	- -	-1.05	-27.63	-6.87	-4.38	-6.08	-12.07	11.4	-1.39	-3.31	2.56	-5.24	0.23
EV/EBITDA High	- -	-1.05	-37.15	-12.73	-9.47	-10.97	-20.07	15.79	-3.97	-7.41	4.49	-8.25	0.23
EV/EBITDA Low	- -	-1.05	-17.12	-4.15	-2.64	-2.46	-4.63	5.63	-0.28	-0.54	1.61	-3.46	0.23
EV/EBIT Average	- -	-1.04	-26.81	-6.77	-4.28	-5.94	-11.43	12.99	-1.29	-2.91	2.66	-4.95	0.22
EV/EBIT High	- -	-1.04	-36.05	-12.54	-9.26	-10.72	-18.99	17.99	-3.69	-6.51	4.66	-7.78	0.22
EV/EBIT Low	- -	-1.04	-16.61	-4.09	-2.58	-2.41	-4.39	6.41	-0.26	-0.47	1.67	-3.26	0.22
Last Price	- -	- -	21.9	12.74	16.6	9.4	13.95	7.15	2.71	6.1	8.44	5.67	3.93
High Price	- -	- -	30.54	21.92	25.99	31.91	28.79	14.8	9.15	10.6	14.34	11.72	6.27
Enterprise Value Average	3	15	543	280	308	541	591	356	95	148	324	412	-29
Enterprise Value High	3	15	730	518	665	976	982	493	271	331	568	648	-29
Enterprise Value Low	3	15	336	169	186	219	227	176	19	24	204	272	-29

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	26	26	25	26	32	32	37	37	38	39	44	55	59
Diluted Weighted Avg Shares	- -	15	25	25	27	32	36	37	38	38	45	58	- -
Basic Weighted Avg Shares	- -	15	25	25	27	32	36	37	38	38	43	58	- -
Revenue per Share	- -	- -	0.7	0.56	0.38	0.24	2.91	4.61	0.99	1.07	5.81	1.39	- -
EBITDA per Share	- -	-0.96	-0.79	-1.61	-2.62	-2.77	-1.36	0.84	-1.82	-1.16	2.94	-1.36	- -
Operating Income per Share	- -	-0.98	-0.81	-1.63	-2.68	-2.84	-1.44	0.74	-1.95	-1.33	2.84	-1.44	- -
Basic EPS, GAAP	- -	-1.11	-1.24	-1.59	-2.64	-2.75	-1.21	0.99	-1.89	-1.21	3.08	-1.13	- -
Basic EPS from Cont Ops	- -	-1.11	-1.19	-1.59	-2.64	-2.75	-1.21	0.99	-1.89	-1.21	3.08	-1.13	- -
Diluted EPS, GAAP	- -	-1.11	-1.24	-1.59	-2.64	-2.75	-1.21	0.98	-1.89	-1.21	2.97	-1.13	- -
Diluted EPS from Cont Ops	- -	-1.11	-1.19	-1.59	-2.64	-2.75	-1.21	0.98	-1.89	-1.21	2.97	-1.13	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.81	1.66	-1.68	-2.29	-0.5	1.36	-2.6	-1.42	-0.33	1.81	-0.27	- -
Free Cash Flow per Basic Share	- -	-1.01	1.62	-1.88	-2.44	-0.63	1.14	-2.93	-1.46	-0.39	1.74	-0.33	- -
Cash & Equivalents per Share	- -	0.48	7.8	6.89	6.31	4.86	7.84	4.88	3.52	3.1	5.37	4.62	- -
Book Value per Share	- -	-1.42	-2	-3.56	-5.99	-8.39	-8.71	-7.43	-9.21	-10.26	-6.07	-5.66	- -
Tangible Book Value per Share	- -	-1.42	6.78	5.37	5	1.45	2.77	4.16	2.52	1.54	5.49	5.2	- -

Voyager Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)